Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05305443Not ApplicableCompleted

COVID-19 Treatment Cascade Optimization Study

Role: collaborator

NCT04757298Not ApplicableCompleted

Optimization of a New Adaptive Intervention to Increase COVID-19 Testing

Role: collaborator

NCT02951455Not ApplicableCompleted

Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use

Role: collaborator

NCT01482923Completed

Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations

Role: collaborator

All 4 trials loaded